1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
Wintjens, R.
Wieruszeski, J.-M.
Drobecq, H.
Lippens, G.
Landrieu, I.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
1
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C4 H10 N O6 P
199.099
n
PHOSPHOTHREONINE
PHOSPHONOTHREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
276
25150
25156
10.1074/jbc.M010327200
11313338
1H NMR study on the binding of Pin1 Trp-Trp domain with phosphothreonine peptides.
2001
10.2210/pdb1i8g/pdb
pdb_00001i8g
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
1192.209
M-PHASE INDUCER PHOSPHATASE 3
3.1.3.48
RESIDUES 63-72
1
syn
polymer
4462.899
PEPTIDYL-PROLYL CIS-TRANS ISOMERASE NIMA-INTERACTING 1
5.2.1.8
WW DOMAIN (RESIDUES 6-44)
1
syn
polymer
no
yes
EQPL(TPO)PVTDL
EQPLTPVTDL
A
polypeptide(L)
no
no
KLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSG
KLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSG
B
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
database_2
pdbx_nmr_software
pdbx_struct_assembly
pdbx_struct_oper_list
struct_conn
struct_ref_seq_dif
repository
Initial release
Version format compliance
Version format compliance
Data collection
Database references
Derived calculations
1
0
2001-07-18
1
1
2008-04-27
1
2
2011-07-13
1
3
2022-02-23
_database_2.pdbx_DOI
_database_2.pdbx_database_accession
_pdbx_nmr_software.name
_struct_conn.pdbx_leaving_atom_flag
_struct_ref_seq_dif.details
1I6C contains the same protein
in a free (not complexed) form
Solution structure of Pin1 WW domain
complexed with human tau phosphothreonine peptide
RCSB
Y
RCSB
2001-03-14
REL
REL
The ligand phosphopeptide was synthesized from Rink amide resin using the Fmoc strategy and activation by HBTU and HOBT in a 431A peptide synthesizer. The sequence of the peptide is naturally found in Xenopus laevis (African clawed frog).
sample
The Pin1 WW domain was obtained by peptide synthesis using the BOC-benzyl strategy and the HBTU in situ activation protocol on an Applied 430A peptide synthesizer. The sequence of the peptide is naturally found in Homo sapiens (Human).
sample
structures with the lowest energy
50
10
2D NOESY
100 mM NaCl
6.4
ambient
285
K
hybrid of distance geometry / simulated annealing protocol
Minimization procedure using CVFF as force field
distance geometry simulated annealing
1
closest to the average
sample of 1mM WW domain / 4.5 mM Cdc25 ligand
buffer of 50 mM deutered Tris-D2O,
pH 6.4, 100 mM NaCl
90% H2O/10% D2O
Brunger, A.T.
structure solution
X-PLOR
3.851
Molecular Simulation Inc.
refinement
Discover
2.98
600
Bruker
DMX
GLU
1
n
1
GLU
1
A
GLN
2
n
2
GLN
2
A
PRO
3
n
3
PRO
3
A
LEU
4
n
4
LEU
4
A
THR
5
n
5
TPO
5
A
PRO
6
n
6
PRO
6
A
VAL
7
n
7
VAL
7
A
THR
8
n
8
THR
8
A
ASP
9
n
9
ASP
9
A
LEU
10
n
10
LEU
10
A
LYS
1
n
1
LYS
1
B
LEU
2
n
2
LEU
2
B
PRO
3
n
3
PRO
3
B
PRO
4
n
4
PRO
4
B
GLY
5
n
5
GLY
5
B
TRP
6
n
6
TRP
6
B
GLU
7
n
7
GLU
7
B
LYS
8
n
8
LYS
8
B
ARG
9
n
9
ARG
9
B
MET
10
n
10
MET
10
B
SER
11
n
11
SER
11
B
ARG
12
n
12
ARG
12
B
SER
13
n
13
SER
13
B
SER
14
n
14
SER
14
B
GLY
15
n
15
GLY
15
B
ARG
16
n
16
ARG
16
B
VAL
17
n
17
VAL
17
B
TYR
18
n
18
TYR
18
B
TYR
19
n
19
TYR
19
B
PHE
20
n
20
PHE
20
B
ASN
21
n
21
ASN
21
B
HIS
22
n
22
HIS
22
B
ILE
23
n
23
ILE
23
B
THR
24
n
24
THR
24
B
ASN
25
n
25
ASN
25
B
ALA
26
n
26
ALA
26
B
SER
27
n
27
SER
27
B
GLN
28
n
28
GLN
28
B
TRP
29
n
29
TRP
29
B
GLU
30
n
30
GLU
30
B
ARG
31
n
31
ARG
31
B
PRO
32
n
32
PRO
32
B
SER
33
n
33
SER
33
B
GLY
34
n
34
GLY
34
B
ASN
35
n
35
ASN
35
B
SER
36
n
36
SER
36
B
SER
37
n
37
SER
37
B
SER
38
n
38
SER
38
B
GLY
39
n
39
GLY
39
B
author_defined_assembly
2
dimeric
A
TPO
5
PHOSPHOTHREONINE
A
TPO
5
THR
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
B
N
ARG
9
B
N
ARG
9
B
O
TYR
18
B
O
TYR
18
B
N
ASN
21
B
N
ASN
21
B
O
ALA
26
B
O
ALA
26
1
A
CB
TPO
5
WRONG HAND
2
A
CB
TPO
5
WRONG HAND
3
A
CB
TPO
5
WRONG HAND
4
A
CB
TPO
5
WRONG HAND
5
A
CB
TPO
5
WRONG HAND
6
A
CB
TPO
5
WRONG HAND
7
A
CB
TPO
5
WRONG HAND
8
A
CB
TPO
5
WRONG HAND
9
A
CB
TPO
5
WRONG HAND
10
A
CB
TPO
5
WRONG HAND
1
A
B
O1P
HG
TPO
SER
5
11
1.45
1
A
B
O2P
HH21
TPO
ARG
5
12
1.58
2
A
B
O1P
HG
TPO
SER
5
11
1.48
2
A
B
O2P
HH21
TPO
ARG
5
12
1.58
2
B
B
HG
OXT
SER
GLY
36
39
1.58
4
B
B
HG
O
SER
GLY
37
39
1.54
4
A
B
O1P
HH21
TPO
ARG
5
12
1.58
5
A
B
O1P
HG
TPO
SER
5
11
1.50
5
A
B
O2P
HH21
TPO
ARG
5
12
1.60
6
A
B
OG1
HG
TPO
SER
5
11
1.55
6
B
B
HG
O
SER
SER
33
36
1.59
8
B
B
HG
OXT
SER
GLY
36
39
1.51
9
B
B
HG
O
SER
GLY
33
39
1.55
10
A
B
O1P
HG
TPO
SER
5
11
1.50
10
B
B
HG
O
SER
GLY
38
39
1.55
1
A
A
LEU
TPO
4
5
126.57
1
A
A
ASP
LEU
9
10
149.71
1
B
B
ARG
SER
12
13
-145.57
1
B
B
GLY
ASN
34
35
138.61
2
B
B
TRP
GLU
6
7
149.07
2
B
B
GLU
ARG
30
31
149.88
3
A
A
GLU
GLN
1
2
142.59
3
B
B
LYS
LEU
1
2
147.81
3
B
B
TRP
GLU
6
7
133.89
3
B
B
SER
SER
37
38
-136.93
4
A
A
VAL
THR
7
8
-148.65
4
A
A
ASP
LEU
9
10
132.49
4
B
B
TRP
GLU
6
7
144.30
4
B
B
TRP
GLU
29
30
-144.06
4
B
B
SER
GLY
38
39
-147.67
5
B
B
TRP
GLU
6
7
140.48
7
A
A
GLN
PRO
2
3
143.83
7
B
B
TRP
GLU
6
7
139.62
7
B
B
PRO
SER
32
33
-141.36
7
B
B
SER
GLY
38
39
-143.37
8
A
A
ASP
LEU
9
10
133.23
8
B
B
TRP
GLU
6
7
148.75
8
B
B
VAL
TYR
17
18
144.92
8
B
B
SER
GLY
38
39
143.00
9
B
B
PRO
SER
32
33
-126.84
9
B
B
SER
GLY
38
39
136.22
10
B
B
SER
GLY
38
39
-135.45
2
B
ARG
9
0.171
SIDE CHAIN
3
B
TYR
19
0.074
SIDE CHAIN
4
B
ARG
12
0.114
SIDE CHAIN
4
B
TYR
19
0.074
SIDE CHAIN
6
B
ARG
12
0.073
SIDE CHAIN
6
B
ARG
31
0.096
SIDE CHAIN
7
B
ARG
31
0.147
SIDE CHAIN
8
B
ARG
12
0.086
SIDE CHAIN
8
B
TYR
19
0.140
SIDE CHAIN
8
B
ARG
31
0.129
SIDE CHAIN
9
B
ARG
31
0.100
SIDE CHAIN
1
-5.50
0.90
109.00
103.50
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
1
4.19
0.50
120.30
124.49
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
1
3.20
0.50
120.30
123.50
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
1
3.44
0.50
120.30
123.74
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
1
-5.47
0.60
121.00
115.53
B
B
B
CB
CG
CD2
TYR
TYR
TYR
19
19
19
N
1
4.81
0.60
121.00
125.81
B
B
B
CB
CG
CD1
TYR
TYR
TYR
19
19
19
N
1
8.41
1.30
111.50
119.91
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
1
4.70
0.50
120.30
125.00
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
2
-5.53
0.90
109.00
103.47
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
2
3.00
0.50
120.30
123.30
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
2
4.31
0.50
120.30
124.61
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
2
8.34
1.30
111.50
119.84
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
2
-12.44
1.80
110.60
98.16
B
B
B
N
CA
CB
ARG
ARG
ARG
31
31
31
N
2
4.08
0.50
120.30
124.38
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
2
-3.14
0.50
120.30
117.16
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
31
31
31
N
3
-12.20
1.80
110.60
98.40
B
B
B
N
CA
CB
TRP
TRP
TRP
6
6
6
N
3
-5.52
0.90
109.00
103.48
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
3
3.91
0.50
120.30
124.21
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
3
4.87
0.50
120.30
125.17
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
3
-3.32
0.50
120.30
116.98
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
12
12
12
N
3
3.78
0.50
120.30
124.08
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
3
8.31
1.30
111.50
119.81
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
3
13.17
2.00
110.40
123.57
B
B
B
CB
CA
C
ARG
ARG
ARG
31
31
31
N
3
3.28
0.50
120.30
123.58
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
4
-11.01
1.80
110.60
99.59
B
B
B
N
CA
CB
TRP
TRP
TRP
6
6
6
N
4
-5.84
0.90
109.00
103.16
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
4
4.25
0.50
120.30
124.55
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
4
5.18
0.50
120.30
125.48
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
4
3.95
0.50
120.30
124.25
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
4
8.46
1.30
111.50
119.96
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
4
3.24
0.50
120.30
123.54
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
5
-11.35
1.80
110.60
99.25
B
B
B
N
CA
CB
TRP
TRP
TRP
6
6
6
N
5
-5.41
0.90
109.00
103.59
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
5
3.30
0.50
120.30
123.60
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
5
4.27
0.50
120.30
124.57
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
5
3.42
0.50
120.30
123.72
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
5
8.22
1.30
111.50
119.72
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
5
3.89
0.50
120.30
124.19
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
5
-3.15
0.50
120.30
117.15
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
31
31
31
N
6
4.23
0.50
120.30
124.53
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
6
4.23
0.50
120.30
124.53
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
6
-3.41
0.50
120.30
116.89
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
12
12
12
N
6
3.77
0.50
120.30
124.07
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
6
8.38
1.30
111.50
119.88
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
6
3.62
0.50
120.30
123.92
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
7
-11.20
1.80
110.60
99.40
B
B
B
N
CA
CB
TRP
TRP
TRP
6
6
6
N
7
-5.75
0.90
109.00
103.25
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
7
3.99
0.50
120.30
124.29
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
7
4.47
0.50
120.30
124.77
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
7
3.86
0.50
120.30
124.16
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
7
8.47
1.30
111.50
119.97
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
8
-5.41
0.90
109.00
103.59
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
8
4.05
0.50
120.30
124.35
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
8
3.69
0.50
120.30
123.99
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
8
3.81
0.50
120.30
124.11
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
8
-3.57
0.50
120.30
116.73
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
16
16
16
N
8
-4.10
0.60
121.00
116.90
B
B
B
CB
CG
CD1
TYR
TYR
TYR
19
19
19
N
8
8.54
1.30
111.50
120.04
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
8
-15.55
1.80
110.60
95.05
B
B
B
N
CA
CB
ARG
ARG
ARG
31
31
31
N
8
3.07
0.50
120.30
123.37
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
9
-6.19
0.90
109.00
102.81
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
9
3.66
0.50
120.30
123.96
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
9
-3.35
0.50
120.30
116.95
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
9
9
9
N
9
3.86
0.50
120.30
124.16
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
9
3.44
0.50
120.30
123.74
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
9
8.36
1.30
111.50
119.86
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
9
12.84
2.00
110.40
123.24
B
B
B
CB
CA
C
ARG
ARG
ARG
31
31
31
N
9
3.75
0.50
120.30
124.05
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
10
-5.60
0.90
109.00
103.40
B
B
B
CD1
NE1
CE2
TRP
TRP
TRP
6
6
6
N
10
3.46
0.50
120.30
123.76
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
9
9
9
N
10
3.96
0.50
120.30
124.26
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
12
12
12
N
10
3.90
0.50
120.30
124.20
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
16
16
16
N
10
-4.49
0.60
121.00
116.51
B
B
B
CB
CG
CD2
TYR
TYR
TYR
19
19
19
N
10
8.39
1.30
111.50
119.89
B
B
B
ND1
CE1
NE2
HIS
HIS
HIS
22
22
22
N
10
4.20
0.50
120.30
124.50
B
B
B
NE
CZ
NH1
ARG
ARG
ARG
31
31
31
N
10
-3.30
0.50
120.30
117.00
B
B
B
NE
CZ
NH2
ARG
ARG
ARG
31
31
31
N
1
A
THR
8
91.27
77.96
1
B
ARG
12
54.32
4.67
1
B
SER
13
69.09
-58.87
1
B
ARG
16
-117.12
-122.45
1
B
ASN
25
78.69
69.95
1
B
PRO
32
-67.50
31.76
1
B
SER
33
73.07
-34.09
1
B
SER
36
-83.60
-140.68
2
A
LEU
4
74.89
77.31
2
A
VAL
7
-94.32
-138.92
2
A
ASP
9
-96.67
-113.83
2
B
LEU
2
48.55
168.59
2
B
SER
11
-76.49
-93.11
2
B
SER
13
69.95
-74.54
2
B
ASN
25
79.31
69.43
2
B
ARG
31
-34.04
123.99
2
B
SER
33
-151.89
-88.92
2
B
SER
37
65.63
-68.21
3
B
LEU
2
-53.22
175.83
3
B
SER
11
-112.86
-96.11
3
B
SER
13
64.99
-81.18
3
B
ASN
25
81.81
73.10
3
B
GLN
28
-123.08
-165.95
3
B
PRO
32
-68.14
26.87
3
B
SER
33
69.64
-55.81
3
B
SER
38
64.10
68.67
4
A
PRO
3
-88.29
-152.52
4
A
TPO
5
-154.23
72.98
4
A
THR
8
73.54
110.04
4
B
GLU
7
-150.73
-155.69
4
B
ARG
12
64.59
-86.52
4
B
SER
13
-161.38
89.68
4
B
ARG
16
-113.90
-134.14
4
B
ASN
25
162.59
-35.79
4
B
GLN
28
-143.57
-151.43
4
B
ARG
31
99.06
133.98
4
B
SER
33
-152.84
-75.38
4
B
ASN
35
-106.84
71.08
4
B
SER
38
67.21
70.57
5
A
VAL
7
-100.85
-140.24
5
B
LEU
2
46.13
-174.59
5
B
ARG
9
-101.54
-153.42
5
B
SER
13
69.12
-63.96
5
B
ARG
16
-112.86
-152.21
5
B
ASN
25
76.27
67.10
5
B
SER
33
-153.16
-87.20
5
B
SER
36
-88.62
-75.53
5
B
SER
37
71.15
-31.03
6
A
VAL
7
53.39
-149.74
6
A
THR
8
-149.48
30.58
6
B
LEU
2
-53.26
172.45
6
B
PRO
3
-47.29
154.99
6
B
SER
11
-93.52
-105.42
6
B
SER
13
70.51
-61.91
6
B
SER
14
-162.07
116.52
6
B
ASN
25
74.44
65.46
6
B
GLN
28
-122.11
-167.55
6
B
SER
33
-135.73
-66.83
6
B
SER
36
58.75
-126.04
6
B
SER
38
-157.28
72.88
7
A
PRO
3
-68.43
97.43
7
A
LEU
4
-104.69
68.87
7
B
PRO
3
-48.93
159.03
7
B
GLU
7
-155.72
-131.59
7
B
ARG
9
-112.07
-159.06
7
B
SER
11
-82.77
-83.74
7
B
SER
14
-65.12
92.29
7
B
ILE
23
75.70
-60.02
7
B
ASN
25
74.94
68.90
7
B
GLU
30
-94.92
-136.47
7
B
PRO
32
-77.00
32.61
7
B
SER
33
61.72
-86.00
7
B
SER
37
-154.26
-65.88
8
A
LEU
4
61.55
75.09
8
A
VAL
7
-89.74
-84.72
8
A
ASP
9
-145.08
-74.81
8
B
LEU
2
43.17
-167.07
8
B
ARG
9
-123.85
-163.32
8
B
SER
11
-69.34
-124.60
8
B
SER
13
67.40
-35.22
8
B
ARG
16
-133.66
-133.39
8
B
ARG
31
-19.79
135.87
8
B
SER
33
-166.66
-101.54
8
B
SER
38
78.62
-49.93
9
A
VAL
7
-84.84
-119.59
9
B
LEU
2
66.61
151.94
9
B
SER
13
69.70
-54.10
9
B
ARG
16
-115.83
-136.69
9
B
HIS
22
-76.95
21.41
9
B
ILE
23
-144.95
-55.47
9
B
ASN
25
80.61
71.22
9
B
PRO
32
-68.81
27.03
9
B
SER
33
71.89
-84.73
9
B
SER
37
-158.83
-46.94
9
B
SER
38
-144.37
-56.79
10
A
LEU
4
-118.91
78.19
10
B
ARG
9
-119.36
-151.77
10
B
SER
13
67.08
-38.40
10
B
ARG
16
-105.21
-140.98
10
B
ASN
25
81.02
78.39
10
B
GLU
30
-120.07
-115.33
10
B
ARG
31
-168.98
110.73
10
B
SER
38
-161.03
-50.64
SOLUTION STRUCTURE OF PIN1 WW DOMAIN COMPLEXED WITH CDC25 PHOSPHOTHREONINE PEPTIDE
1
N
N
2
N
N
covale
1.335
both
A
LEU
4
A
C
LEU
4
1_555
A
TPO
5
A
N
TPO
5
1_555
covale
1.370
both
A
TPO
5
A
C
TPO
5
1_555
A
PRO
6
A
N
PRO
6
1_555
HYDROLASE/ISOMERASE
CELL DIVISION, NUCLEAR PROTEIN, HYDROLASE-ISOMERASE COMPLEX
MPIP3_XENLA
UNP
1
63
P30311
EQPLTPVTDL
PIN1_HUMAN
UNP
2
6
Q13526
KLPPGWEKRMSRSSGRVYYFNHITNASQWERPSGNSSSG
63
72
1I8G
1
10
P30311
A
1
1
10
6
44
1I8G
1
39
Q13526
B
2
1
39
1
THR
modified residue
TPO
5
1I8G
A
P30311
UNP
67
5
3
anti-parallel
anti-parallel
B
TRP
6
B
TRP
6
B
MET
10
B
MET
10
B
VAL
17
B
VAL
17
B
ASN
21
B
ASN
21
B
ALA
26
B
ALA
26
B
GLN
28
B
GLN
28